325 related articles for article (PubMed ID: 15480426)
1. Thioredoxin modulates activator protein 1 (AP-1) activity and p27Kip1 degradation through direct interaction with Jab1.
Hwang CY; Ryu YS; Chung MS; Kim KD; Park SS; Chae SK; Chae HZ; Kwon KS
Oncogene; 2004 Nov; 23(55):8868-75. PubMed ID: 15480426
[TBL] [Abstract][Full Text] [Related]
2. Intracellular action of the cytokine MIF to modulate AP-1 activity and the cell cycle through Jab1.
Kleemann R; Hausser A; Geiger G; Mischke R; Burger-Kentischer A; Flieger O; Johannes FJ; Roger T; Calandra T; Kapurniotu A; Grell M; Finkelmeier D; Brunner H; Bernhagen J
Nature; 2000 Nov; 408(6809):211-6. PubMed ID: 11089976
[TBL] [Abstract][Full Text] [Related]
3. Direct association of hepatopoietin with thioredoxin constitutes a redox signal transduction in activation of AP-1/NF-kappaB.
Li Y; Liu W; Xing G; Tian C; Zhu Y; He F
Cell Signal; 2005 Aug; 17(8):985-96. PubMed ID: 15894171
[TBL] [Abstract][Full Text] [Related]
4. Prognostic significance of Jab1 expression in laryngeal squamous cell carcinomas.
Dong Y; Sui L; Watanabe Y; Yamaguchi F; Hatano N; Tokuda M
Clin Cancer Res; 2005 Jan; 11(1):259-66. PubMed ID: 15671554
[TBL] [Abstract][Full Text] [Related]
5. Prognostic significance of localized p27Kip1 and potential role of Jab1/CSN5 in pancreatic cancer.
Fukumoto A; Ikeda N; Sho M; Tomoda K; Kanehiro H; Hisanaga M; Tsurui Y; Tsutsumi M; Kato JY; Nakajima Y
Oncol Rep; 2004 Feb; 11(2):277-84. PubMed ID: 14719054
[TBL] [Abstract][Full Text] [Related]
6. Basic investigation on the development of molecular targeting therapy against cyclin-dependent kinase inhibitor p27Kip1 in head and neck cancer cells.
Supriatno ; Harada K; Yoshida H; Sato M
Int J Oncol; 2005 Sep; 27(3):627-35. PubMed ID: 16077910
[TBL] [Abstract][Full Text] [Related]
7. Jun activation domain-binding protein 1 expression in breast cancer inversely correlates with the cell cycle inhibitor p27(Kip1).
Kouvaraki MA; Rassidakis GZ; Tian L; Kumar R; Kittas C; Claret FX
Cancer Res; 2003 Jun; 63(11):2977-81. PubMed ID: 12782606
[TBL] [Abstract][Full Text] [Related]
8. Adapter protein NRBP associates with Jab1 and negatively regulates AP-1 activity.
Wang H; Sun X; Luo Y; Lin Z; Wu J
FEBS Lett; 2006 Oct; 580(25):6015-21. PubMed ID: 17052710
[TBL] [Abstract][Full Text] [Related]
9. Tumor suppressor VDUP1 increases p27(kip1) stability by inhibiting JAB1.
Jeon JH; Lee KN; Hwang CY; Kwon KS; You KH; Choi I
Cancer Res; 2005 Jun; 65(11):4485-9. PubMed ID: 15930262
[TBL] [Abstract][Full Text] [Related]
10. Degradation of the cyclin-dependent-kinase inhibitor p27Kip1 is instigated by Jab1.
Tomoda K; Kubota Y; Kato J
Nature; 1999 Mar; 398(6723):160-5. PubMed ID: 10086358
[TBL] [Abstract][Full Text] [Related]
11. Thioredoxin nuclear translocation and interaction with redox factor-1 activates the activator protein-1 transcription factor in response to ionizing radiation.
Wei SJ; Botero A; Hirota K; Bradbury CM; Markovina S; Laszlo A; Spitz DR; Goswami PC; Yodoi J; Gius D
Cancer Res; 2000 Dec; 60(23):6688-95. PubMed ID: 11118054
[TBL] [Abstract][Full Text] [Related]
12. Thioredoxin reductase regulates AP-1 activity as well as thioredoxin nuclear localization via active cysteines in response to ionizing radiation.
Karimpour S; Lou J; Lin LL; Rene LM; Lagunas L; Ma X; Karra S; Bradbury CM; Markovina S; Goswami PC; Spitz DR; Hirota K; Kalvakolanu DV; Yodoi J; Gius D
Oncogene; 2002 Sep; 21(41):6317-27. PubMed ID: 12214272
[TBL] [Abstract][Full Text] [Related]
13. Jab1 expression is associated with inverse expression of p27(kip1) and poor prognosis in epithelial ovarian tumors.
Sui L; Dong Y; Ohno M; Watanabe Y; Sugimoto K; Tai Y; Tokuda M
Clin Cancer Res; 2001 Dec; 7(12):4130-5. PubMed ID: 11751512
[TBL] [Abstract][Full Text] [Related]
14. Immunohistochemical study of Skp2 and Jab1, two key molecules in the degradation of P27, in lung adenocarcinoma.
Goto A; Niki T; Moriyama S; Funata N; Moriyama H; Nishimura Y; Tsuchida R; Kato JY; Fukayama M
Pathol Int; 2004 Sep; 54(9):675-81. PubMed ID: 15363035
[TBL] [Abstract][Full Text] [Related]
15. A new group of conserved coactivators that increase the specificity of AP-1 transcription factors.
Claret FX; Hibi M; Dhut S; Toda T; Karin M
Nature; 1996 Oct; 383(6599):453-7. PubMed ID: 8837781
[TBL] [Abstract][Full Text] [Related]
16. HER-2/neu transcriptionally activates Jab1 expression via the AKT/beta-catenin pathway in breast cancer cells.
Hsu MC; Chang HC; Hung WC
Endocr Relat Cancer; 2007 Sep; 14(3):655-67. PubMed ID: 17914096
[TBL] [Abstract][Full Text] [Related]
17. Jun activation domain binding protein 1 expression is associated with low p27(Kip1)levels in node-negative breast cancer.
Esteva FJ; Sahin AA; Rassidakis GZ; Yuan LX; Smith TL; Yang Y; Gilcrease MZ; Cristofanilli M; Nahta R; Pusztai L; Claret FX
Clin Cancer Res; 2003 Nov; 9(15):5652-9. PubMed ID: 14654548
[TBL] [Abstract][Full Text] [Related]
18. JAB1 enhances HAND2 transcriptional activity by regulating HAND2 DNA binding.
Dai YS; Hao J; Bonin C; Morikawa Y; Cserjesi P
J Neurosci Res; 2004 Jun; 76(5):613-22. PubMed ID: 15139020
[TBL] [Abstract][Full Text] [Related]
19. Jun activation domain-binding protein 1 expression in malignant lymphoma of the thyroid: its linkage to degree of malignancy and p27 expression.
Ito Y; Yoshida H; Matsuzuka F; Matsuura N; Nakamura Y; Nakamine H; Kakudo K; Kuma K; Miyauchi A
Anticancer Res; 2003; 23(5b):4121-5. PubMed ID: 14666612
[TBL] [Abstract][Full Text] [Related]
20. Psoriasin interacts with Jab1 and influences breast cancer progression.
Emberley ED; Niu Y; Leygue E; Tomes L; Gietz RD; Murphy LC; Watson PH
Cancer Res; 2003 Apr; 63(8):1954-61. PubMed ID: 12702588
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]